Enpro Inc.'s (NYSE:NPO) Price In Tune With Earnings

Enpro Inc.'s (NYSE:NPO) price-to-earnings (or "P/E") ratio of 56.2x might make it look like a strong sell right now compared to the market in the United States, where around half of the companies have P/E ratios below 18x and even P/E's below 10x are quite common. However, the P/E might be quite high for a reason and it requires further investigation to determine if it's justified.

With earnings growth that's superior to most other companies of late, Enpro has been doing relatively well. The P/E is probably high because investors think this strong earnings performance will continue. If not, then existing shareholders might be a little nervous about the viability of the share price.

See our latest analysis for Enpro

pe-multiple-vs-industry
NYSE:NPO Price to Earnings Ratio vs Industry October 31st 2025
If you'd like to see what analysts are forecasting going forward, you should check out our free report on Enpro.
Advertisement

What Are Growth Metrics Telling Us About The High P/E?

In order to justify its P/E ratio, Enpro would need to produce outstanding growth well in excess of the market.

Retrospectively, the last year delivered an exceptional 97% gain to the company's bottom line. The strong recent performance means it was also able to grow EPS by 38% in total over the last three years. Accordingly, shareholders would have probably welcomed those medium-term rates of earnings growth.

Turning to the outlook, the next year should generate growth of 35% as estimated by the three analysts watching the company. That's shaping up to be materially higher than the 15% growth forecast for the broader market.

In light of this, it's understandable that Enpro's P/E sits above the majority of other companies. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.

The Key Takeaway

Generally, our preference is to limit the use of the price-to-earnings ratio to establishing what the market thinks about the overall health of a company.

We've established that Enpro maintains its high P/E on the strength of its forecast growth being higher than the wider market, as expected. At this stage investors feel the potential for a deterioration in earnings isn't great enough to justify a lower P/E ratio. It's hard to see the share price falling strongly in the near future under these circumstances.

Before you take the next step, you should know about the 1 warning sign for Enpro that we have uncovered.

If P/E ratios interest you, you may wish to see this free collection of other companies with strong earnings growth and low P/E ratios.

Valuation is complex, but we're here to simplify it.

Discover if Enpro might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NYSE:NPO

Enpro

An industrial technology company, design, develops, manufactures, and markets proprietary, value-added products and solutions to safeguard critical environments in the United States, Europe, Asia Pacific, and internationally.

Excellent balance sheet with moderate growth potential.

Advertisement

Weekly Picks

LO
Lou_Basenese
CUE logo
Lou_Basenese on Cue Biopharma ·

Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

Fair Value:US$7057.7% undervalued
9 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative
HE
HedgeY
ASTS logo
HedgeY on AST SpaceMobile ·

AST SpaceMobile: The Boldest Direct-to-Cell Bet in Public Markets

Fair Value:US$17036.9% undervalued
33 users have followed this narrative
0 users have commented on this narrative
10 users have liked this narrative
FU
ONTO logo
FundamentalFlow on Onto Innovation ·

Onto Innovation: The Advanced Packaging Chokepoint 51.3% undervalued intrinsic discount

Fair Value:US$38027.7% undervalued
23 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
MA
martinarauz
NU logo
martinarauz on Nu Holdings ·

Investment Analysis (May 2026)

Fair Value:US$22.7446.7% undervalued
55 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative

Updated Narratives

IM
Imthetxarbi
SLP logo
Imthetxarbi on Sylvania Platinum ·

A Debt-Free PGM Producer Trading at 2x EBITDA With a 10% Dividend Yield Nobody Is Talking About

Fair Value:UK£2.0855.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MI
Miracleworker
DEC logo
Miracleworker on Diversified Energy ·

DEC.L: Dip-Buying Opp, 8%+ Div & 57-100% Potential Gain Over 12 Months

Fair Value:UK£10.460% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
IM
Imthetxarbi
WOSG logo
Imthetxarbi on Watches of Switzerland Group ·

A Compelling Compounder at a Retailer's Multiple

Fair Value:UK£1134.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8589.3% undervalued
124 users have followed this narrative
3 users have commented on this narrative
36 users have liked this narrative
CL
Clive_Thompson
TTWO logo
Clive_Thompson on Take-Two Interactive Software ·

Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

Fair Value:US$276.9721.8% undervalued
56 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
NI
niteco
HON logo
niteco on Honeywell International ·

Honeywell - The Demand-Side of the AI Infrastructure

Fair Value:US$320.1932.0% undervalued
46 users have followed this narrative
0 users have commented on this narrative
19 users have liked this narrative